BioCatalyst

QTX-2101 + ATRA, IV arsenic trioxide (ATO) + ATRA — catalyst calendar

1 verified catalyst event(s) referencing QTX-2101 + ATRA, IV arsenic trioxide (ATO) + ATRA, each linked to its official source. Verified as of 2026-10-30.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-03 (month)
in 4mo
ESTIMATED
 READOUT
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acu
Phase 3 · Acute Promyelocytic Leukemia (APL), Acute Promyelocytic Leukaemia
 Quetzal Therapeutics QTX-2101 + ATRA, IV arsenic trioxide (AT ClinicalTrials.gov ↗
✓ Source-checked 2026-10-30
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.